Showing results (1281-1290 of 1,431) with videos related to

Sort By:
Pageof 144
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2018
Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II studyS Banerjee, A M Oza, M J Birrer, et al.
Gynecologic Oncology|January 22, 2021
Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective studySoyoun Rachel Kim, Alicia Tone, Raymond H Kim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 11, 2022
Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancersSoyoun Rachel Kim, Alicia Tone, Raymond Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2019
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA TrialJosep M Del Campo, Ursula A Matulonis, Susanne Malander, et al.
Gynecologic Oncology|October 10, 2025
Multidisciplinary ambulatory management of malignant bowel obstruction (MAMBO) program in patients with advanced gynecological cancers: A prospective studyV Garg, E Armstrong, A Celeste, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2011
Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancerJonathan A Ledermann, Christian Marth, Mark S Carey, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 1, 2021
ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancerBradley J Monk, Robert L Coleman, Keiichi Fujiwara, et al.
Circulation. Arrhythmia and Electrophysiology|November 13, 2020
Hybrid Convergent Procedure for the Treatment of Persistent and Long-Standing Persistent Atrial Fibrillation: Results of CONVERGE Clinical TrialDavid B DeLurgio, Karl J Crossen, Jaswinder Gill, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 7, 2024
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancerRachel Grisham, Bradley J Monk, Els Van Nieuwenhuysen, et al.
JACC. Clinical Electrophysiology|June 9, 2023
High-Frequency Low-Tidal Volume Ventilation Improves Long-Term Outcomes in AF Ablation: A Multicenter Prospective StudyJose Osorio, Paul C Zei, Juan C Díaz, et al.
Pageof 144